02 Jun, EOD - Indian

SENSEX 81373.75 (-0.09)

Nifty 50 24716.6 (-0.14)

Nifty Bank 55903.4 (0.28)

Nifty IT 37061.85 (-0.70)

Nifty Midcap 100 57775.55 (0.62)

Nifty Next 50 67039.8 (0.42)

Nifty Pharma 21394.1 (-0.22)

Nifty Smallcap 100 18095.55 (1.19)

02 Jun, EOD - Global

NIKKEI 225 37470.67 (-1.30)

HANG SENG 23157.97 (-0.57)

S&P 5952.07 (0.33)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoAkums Drugs & Pharmaceuticals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 544222 | NSE Symbol : AKUMS | ISIN : INE09XN01023 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
19-May-2025 26-May-2025 Accounts Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Un-audited (Standalone & Consolidated) Financial Results for the quarter ended on 31st March 2025 and Audited (Standalone & Consolidated) Financial statements for the year ended on 31st March 2025 Outcome of Board Meeting (As Per BSE Announcement Dated on: 26.05.2025)
01-Feb-2025 06-Feb-2025 Quarterly Results Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve approval of Un-audited Financial Results for the quarter and nine months ended 31st December 2024. Respected Sir/Madam, In terms of Regulation 30 and 33 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company in its meeting held today i.e. 6th February, 2025 has inter-alia considered and approved the following: (As per BSE Announcement Dated on 06/02/2025)
05-Nov-2024 09-Nov-2024 Quarterly Results Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the quarter and half year ended on 30th September 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on: 09/11/2024)
21-Aug-2024 24-Aug-2024 Quarterly Results Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2024 inter alia to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the quarter ended 30th June 2024. Outcome of Board Meeting (As per BSE Announcement Dated on 24/08/2024)

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +